Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
| Country | United States |
|---|---|
| Deadline | 2029-11-16 (1090 days left) |
| Published | 2026-11-03 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-28-042. CFDA: 93.CA1
The buyer, the value, the full description and the link to the official notice are available with a free account.